• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

迈向欧洲关于开展和报告卫生经济评估的共识——来自国际药物经济学与结果研究协会(ISPOR)首届欧洲会议的报告

Towards a European consensus on conducting and reporting health economic evaluations--a report from the ISPOR Inaugural European Conference.

作者信息

Goetghebeur M M, Rindress D

机构信息

BioMedCom Consultants inc, Montréal, Québec, Canada.

出版信息

Value Health. 1999 Jul-Aug;2(4):281-7. doi: 10.1046/j.1524-4733.1999.24002.x.

DOI:10.1046/j.1524-4733.1999.24002.x
PMID:16674318
Abstract

This report is a summary of key issues in consensus development regarding the conduct and reporting of health economic research in the European context, presented and discussed at the ISPOR Inaugural European Conference in Cologne, Germany, December 1998. Recommendations of the Harmonization by Consensus of the Methodology for Economic Evaluation of Health Care Technologies in the European Union (HARMET) project were presented, as well as two instruments under development: software for Reporting Economic Evaluation Results (REER) and software for collecting and managing cost data called the Health Cost Database Software (HCDS). Working independently, but interrelated with the objectives of the HARMET initiative, preliminary results from the ongoing European Network on Methodology and Application of Economic Evaluation Techniques (EUROMET) project were presented. Each presentation was followed by an expert discussion panel with audience participation. Issues raised included the development of standards and related topics such as usefulness to European decision-makers, and education and training in health economics in Europe.

摘要

本报告是关于欧洲背景下卫生经济研究的开展与报告的共识发展关键问题的总结,于1998年12月在德国科隆举行的国际药效经济学和结果研究协会(ISPOR)首届欧洲会议上进行了展示和讨论。会上介绍了欧盟卫生保健技术经济评估方法共识协调(HARMET)项目的建议,以及正在开发的两个工具:报告经济评估结果软件(REER)和用于收集与管理成本数据的软件——卫生成本数据库软件(HCDS)。与HARMET倡议的目标相互独立但又相关,会上展示了正在进行的欧洲经济评估技术方法与应用网络(EUROMET)项目的初步结果。每场展示之后都有一个专家讨论小组,并邀请观众参与。提出的问题包括标准的制定以及相关主题,如对欧洲决策者的实用性,以及欧洲卫生经济学的教育与培训。

相似文献

1
Towards a European consensus on conducting and reporting health economic evaluations--a report from the ISPOR Inaugural European Conference.迈向欧洲关于开展和报告卫生经济评估的共识——来自国际药物经济学与结果研究协会(ISPOR)首届欧洲会议的报告
Value Health. 1999 Jul-Aug;2(4):281-7. doi: 10.1046/j.1524-4733.1999.24002.x.
2
Recommendations for reporting economic evaluations of haemophilia prophylaxis: a nominal groups consensus statement on behalf of the Economics Expert Working Group of The International Prophylaxis Study Group.血友病预防措施经济评估报告建议:代表国际预防研究小组经济专家工作组的名义小组共识声明
Haemophilia. 2008 Jan;14(1):127-32. doi: 10.1111/j.1365-2516.2007.01562.x. Epub 2007 Nov 13.
3
Procedures and methods of benefit assessments for medicines in Germany.德国药品效益评估的程序和方法。
Eur J Health Econ. 2008 Nov;9 Suppl 1:5-29. doi: 10.1007/s10198-008-0122-5.
4
[Comments by the Working Group for Methods of Economic Evaluation in Health Care (AG MEG) to IQWiG's Draft Guidelines "Methods for Assessment of the Relation of Benefits to Costs in the German Statutory Health Care System"].[医疗保健经济评估方法工作组(AG MEG)对IQWiG《德国法定医疗保健系统中效益与成本关系评估方法》指南草案的评论]
Gesundheitswesen. 2008 Jun;70(6):e1-16. doi: 10.1055/s-2008-1077059.
5
[Procedures and methods of benefit assessments for medicines in Germany].[德国药品效益评估的程序和方法]
Dtsch Med Wochenschr. 2008 Dec;133 Suppl 7:S225-46. doi: 10.1055/s-0028-1100954. Epub 2008 Nov 25.
6
Presentation of economic evaluation results.经济评估结果的呈现。
J Med Assoc Thai. 2008 Jun;91 Suppl 2:S66-73.
7
Cost-effectiveness analysis in severe mental illness: outcome measures selection.重度精神疾病的成本效益分析:结局指标的选择
J Ment Health Policy Econ. 2007 Jun;10(2):101-8.
8
European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I.欧洲生殖细胞癌诊断与治疗共识会议:欧洲生殖细胞癌共识小组(EGCCCG)第二次会议报告:第一部分
Eur Urol. 2008 Mar;53(3):478-96. doi: 10.1016/j.eururo.2007.12.024. Epub 2007 Dec 26.
9
Cost of depression in Europe.欧洲抑郁症的成本。
J Ment Health Policy Econ. 2006 Jun;9(2):87-98.
10
Project of Polish guidelines for conducting pharmacoeconomic evaluations in comparison to international health economic guidelines.与国际卫生经济指南相比的波兰药物经济学评价实施指南项目
Eur J Health Econ. 2003 Nov;4(4):296-303. doi: 10.1007/s10198-003-0185-2.

引用本文的文献

1
Engaging with economic evaluation methods: insights from small and medium enterprises in the UK medical devices industry after training workshops.参与经济评估方法:培训研讨会后英国医疗器械行业中小企业的见解。
Health Res Policy Syst. 2012 Sep 3;10:29. doi: 10.1186/1478-4505-10-29.
2
Presenting Germany's drug pricing rule as a cost-per-QALY rule.将德国的药品定价规则表述为每质量调整生命年成本规则。
Health Care Manag Sci. 2012 Jun;15(2):103-7. doi: 10.1007/s10729-011-9186-3. Epub 2011 Dec 21.
3
Sensitivity analysis in cost-effectiveness studies: from guidelines to practice.
成本效益研究中的敏感性分析:从指南到实践。
Pharmacoeconomics. 2011 Apr;29(4):297-314. doi: 10.2165/11584630-000000000-00000.